Trial Details
RECRUITINGBasic Information
| Clinical ID | c791 |
|---|---|
| Identifier | NCT06045754 |
| Trial Title | A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Vedolizumab|DRUG: Adalimumab|DRUG: Ustekinumab|DRUG: Ustekinumab |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2024-04-18 |
|---|---|
| Primary Completion Date | 2027-06-28 |
| Completion Date | 2027-06-28 |